Stock Price
2,290.00
Daily Change
37.00 1.64%
Monthly
-1.66%
Yearly
16.55%
Q2 Forecast
2,225.24

Lupin reported INR74.75B in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
Bharat Petroleum INR 1.24T 150B Mar/2026
Cipla INR 65.41B 9.77B Mar/2026
Divis Laboratories Ltd INR 26.04B 1.11B Dec/2025
Dr.Reddys Laboratories INR 75.46B 11.81B Mar/2026
Sun Pharmaceuticals INR 147.99B 3.21B Dec/2025
UPL INR 183.35B 59.74B Mar/2026